144 related articles for article (PubMed ID: 36739741)
1. Identification and detection of plasma extracellular vesicles-derived biomarkers for esophageal squamous cell carcinoma diagnosis.
Zhu Q; Xu H; Huang L; Luo J; Li H; Yang R; Liu X; Liu F
Biosens Bioelectron; 2023 Apr; 225():115088. PubMed ID: 36739741
[TBL] [Abstract][Full Text] [Related]
2. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Response to Chemoradiotherapy by Dynamic Changes of Circulating Exosome Levels in Patients with Esophageal Squamous Cell Carcinoma.
Zhang C; Guo Z; Jing Z
Int J Nanomedicine; 2024; 19():1351-1362. PubMed ID: 38352821
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Esophageal Squamous Cell Carcinoma by High-Performance Serum Metabolic Fingerprints: A Retrospective Study.
Huang Y; Yang H; Li J; Wang F; Liu W; Liu Y; Wang R; Duan L; Wu J; Gao Z; Cao J; Bian F; Zhang J; Zhao F; Yang S; Cao S; Yang A; Wang X; Geng M; Hao A; Li J; Cao J; Li C; Zhang Z; Zhang N; Huang Y; Zhang Y; Qian K; Zhou F
Small Methods; 2024 Jan; 8(1):e2301046. PubMed ID: 37803160
[TBL] [Abstract][Full Text] [Related]
6. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma.
Xie K; Zheng C; Gu W; Jiang Z; Luo C; Luo J; Diao Y; Wang G; Cong Z; Yao X; Hu L; Shen Y
Thorac Cancer; 2022 Dec; 13(23):3341-3352. PubMed ID: 36266257
[TBL] [Abstract][Full Text] [Related]
7. circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling.
Hu X; Wu D; He X; Zhao H; He Z; Lin J; Wang K; Wang W; Pan Z; Lin H; Wang M
Mol Cancer; 2019 Nov; 18(1):160. PubMed ID: 31722716
[TBL] [Abstract][Full Text] [Related]
8. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
9. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
12. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
Wang C; Sun G; Wang H; Dai L; Zhang J; Du R
BMC Cancer; 2022 Aug; 22(1):932. PubMed ID: 36038839
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma.
Liao Y; Xing S; Xu B; Liu W; Zhang G
Oncotarget; 2017 May; 8(18):30050-30062. PubMed ID: 28415791
[TBL] [Abstract][Full Text] [Related]
15. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
Wang M; Smith JS; Wei WQ
Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
[TBL] [Abstract][Full Text] [Related]
16. Raman spectroscopy and machine learning for the classification of esophageal squamous carcinoma.
Huang W; Shang Q; Xiao X; Zhang H; Gu Y; Yang L; Shi G; Yang Y; Hu Y; Yuan Y; Ji A; Chen L
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121654. PubMed ID: 35878494
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
Cui Y; Xue Y; Dong S; Zhang P
J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
[TBL] [Abstract][Full Text] [Related]
18. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
[TBL] [Abstract][Full Text] [Related]
19. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
